Proactive’s Post

London's FTSE 100 fell by 30 points to 8,354 as trading got underway on Friday. Boohoo shares slumped early on as the retailer was among the few to update with news its chief executive was to step down as a business review was launched. Figures for the first half of the year also showed the retailer’s revenues and adjusted earnings falling. Elsewhere, Mothercare shares jumped almost 50% after its report signalled a swing to statutory profit in 2023, despite a drop in sales on pressure in the Middle East. ONS data in the meantime showed sales across Britain’s retail sector grew by just 0.3% in September against August’s 1.0% uptick. And finally, gold brushed new record highs on Friday morning, topping the US$2,700 an ounce mark for the first time. Watch at #Proactive #ProactiveInvestors http://ow.ly/7aH4105MfBu

Shares in Oncimmune Holdings PLC (AIM:ONC) were up 7% in the first hour of trading as a fundraiser and debt restructuring were well received by the market. The autoantibody profiling specialist stands to bring in a minimum of £2 million from a share placing, board subscription and retail offer of stock. At the same time, the company's commercial success has allowed it to convert half its €4 million of debt to equity, leaving it with a more manageable balance sheet. "We are grateful to both our investors and debt provider IPF for supporting this fundraising which has enabled a recapitalisation of the business," said chief executive Martin Gouldstone.  "With a massively improved debt profile and balance sheet, we look forward to continuing to drive the commercialisation of our autoantibody profiling platform which is exhibiting significant commercial traction." At 8.57 am the shares were up 1p at 14.9p.       More at #Proactive #ProactiveInvestors http://ow.ly/Jomo105MfzP

Oncimmune shares up 7% as market applauds recapitalisation @OncimmuneECDT #AIM #ONC. Shares in Oncimmune Holdings PLC (AIM:ONC) were up 7% in the first hour of trading as a fundraiser and debt restructuring were well received by the market. The autoantibody profiling specialist stands to bring in a minimum of £2 million from a share placing, board subscription and retail offer of stock. At the same time, the company's commercial success has allowed it to convert half its €4 million of debt to equity, leaving it with a more manageable balance sheet. "We are grateful to both our investors and debt provider IPF for supporting this fundraising which has enabled a... http://ow.ly/Jomo105MfzP

Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) confirmed it had begun talks with potential end users of the product from the Phalaborwa project in South Africa. Securing customers, known as 'off-takers' in the industry parlance, is an important part of the jigsaw as management looks to secure project finance for the operation, which is slated to open in 2027. The update was shared alongside annual results, highlighting a year of significant progress. During this period, the company received a $50 million investment proposal from the US International Development Corporation. Shortly after the year-end, it secured a royalty and placement agreement with the mining fund Ecora, further strengthening its financial position. More at #Proactive #ProactiveInvestors http://ow.ly/Tbsl105Mfv4

Union Jack Oil plc (AIM:UJO, OTCQB:UJOGF) and Europa Oil & Gas Plc(AIM:EOG) have given an update regarding the planning status for their Wressle well site. The companies told investors that North Lincolnshire Council (NLC) will not resist the proposed legal challenge brought in respect of NLC's decision to grant planning consent for the further development of Wressle. It comes after environmentalists wrote a letter challenging the process undertaken previously. That proposed challenge stemmed from the council's decision to omit the requirement for data on Scope 3 greenhouse gas emissions during the planning approval process. “Having sought their own legal advice, the Wressle Joint Venture partners have concluded they would not be in a position to defend the proposed legal claim,” the companies said in separate but identical statements. “As such it is fully expected that the planning consent will be... More at #Proactive #ProactiveInvestors http://ow.ly/FNN1105MfuN

IOFINA PLC (AIM:IOF, OTC:IOFNF) CEO Tom Becker described the company's performance in the third as 'excellent' as it increased its iodine production and said it was planning further expansion with new plants. Output was 163.9 metric tonnes of crystalline iodine, up from 156.9 MT the previous year, with its new IO#10 plant beginning operations. Strong demand has increased iodine prices, a trend expected to continue into 2025. As part of its growth strategy, Iofina is set to begin construction on its next plant, IO#11, later this year. Plans for additional plants are already in progress. The company remains on track to meet its second-half production target of 355-380 MT. "The group has delivered an excellent performance in the period, with major milestones achieved," said Becker. More at #Proactive #ProactiveInvestors http://ow.ly/qhPS105Mfu0

Keywords Studios PLC (AIM:KWS, OTC:KYYWF) has entered into an agreement to acquire Certain Affinity, a US-based game-development studio known for co-development services on major AAA multiplayer titles. The acquisition aims to strengthen Keywords' Create division, particularly in the action genre, and expand its presence in the US and Canada. Founded in 2006, Certain Affinity has contributed to high-profile franchises such as Halo, Call of Duty, Hogwarts Legacy, and DOOM.  Services provided by Certain Affinity include end-to-end game design, user experience, multiplayer design, and audio and cinematics. It is currently working on EXODUS from Archetype Entertainment, a division of game developer and publisher Wizards of the Coast. Certain Affinity employs over 180 people across offices in Austin, Texas, and Toronto, Ontario. More at #Proactive #ProactiveInvestors http://ow.ly/AucO105Mfs8

Proactive’s Tylah Tully provides a market wrap for October 18. The ASX was on track to close down by 0.9%, sitting at 8,281 points at the time of the update. Over the past five days, the index had gained 0.81% but remained 1.23% below its 52-week high. Top performers of the day included Telix Pharmaceuticals, which saw a 4.17% increase in its share price to A$21.88 after filing a registration statement with the US Securities and Exchange Commission for a proposed Nasdaq listing. Perpetual Limited also rose by 3.97% to A$20.43 despite no specific news. Declining stocks included Flight Centre Travel Group, which dropped 20% to A$17.36 following its presentation at the Morgan Conference. The company reported a decline in revenue margins from 12.9% in FY2019 to 11.4% in FY2024. Sector-wise, all sectors were down, with Utilities being the worst performer, dropping 3.11%. Watch at #Proactive #ProactiveInvestors http://ow.ly/Ox35105Mfp6

Rainbow Rare speaking to 'off-takers' @RainbowREarths #LSE #OTC #RBW #RBWRF. Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) confirmed it had begun talks with potential end users of the product from the Phalaborwa project in South Africa. Securing customers, known as 'off-takers' in the industry parlance, is an important part of the jigsaw as management looks to secure project finance for the operation, which is slated to open in 2027. The update was shared alongside annual results, highlighting a year of significant progress. During this period, the company received a $50 million investment proposal from the US International Development Corporation. Shortly... http://ow.ly/Tbsl105Mfv4

Iofina CEO hails 'excellent' Q3 performance @iofinaplc #AIM #OTC #IOF #IOFNF. Iofina PLC (AIM:IOF, OTC:IOFNF) CEO Tom Becker described the company's performance in the third as 'excellent' as it increased its iodine production and said it was planning further expansion with new plants. Output was 163.9 metric tonnes of crystalline iodine, up from 156.9 MT the previous year, with its new IO#10 plant beginning operations. Strong demand has increased iodine prices, a trend expected to continue into 2025. As part of its growth strategy, Iofina is set to begin construction on its next plant, IO#11, later this year. Plans for additional plants are already in... http://ow.ly/qhPS105Mfu0